Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. The Director, US Medical Affairs, Empasiprubart/Neuromuscular Pipeline will be an integral part of the US Medical Affairs team involved in the development and execution of the Medical Affairs strategy and tactics for development assets specifically, empasiprubart, with some input on other emerging assets. Reporting to the Head of Neuromuscular Therapeutic Area, this leader will work closely with cross-functionals teams to lead medical strategy/planning. Additionally, the Medical Director will be accountable for developing strong external relationships with top Key Opinion Leaders and Healthcare Providers to further our mission to improve patient care.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
1,001-5,000 employees